IMPACT OF PHARMACOGENOMICS ON PERSONALIZED MEDICINE: A COMPREHENSIVE REVIEW
Main Article Content
Keywords
Pharmacogenomics, personalized medicine, genetic variations, drug metabolism, drug efficacy, adverse reactions
Abstract
Pharmacogenomics, the study of how an individual's genetic makeup influences their response to drugs, has revolutionized the field of personalized medicine. Understanding how genetic variations can impact drug metabolism, efficacy, and side effects has the potential to transform the way healthcare is delivered, allowing for more precise and effective treatment strategies tailored to an individual's unique genetic profile. This comprehensive review examines the impact of pharmacogenomics on personalized medicine, exploring the methods used to study genetic variations, the results of research in this field, and the implications for clinical practice. By incorporating pharmacogenomics into personalized medicine, healthcare providers can optimize drug therapy, minimize adverse reactions, and improve patient outcomes.
References
2. Relling MV, Klein TE. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin Pharmacol Ther. 2011;89(3):464-467.
3. Frueh FW, Amur S, Mummaneni P, et al. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. Pharmacotherapy. 2008;28(8):992-998.
4. Sadee W, Dai Z. Pharmacogenetics/genomics and personalized medicine. Hum Mol Genet. 2005;14(R2):R207-R214.
5. Johnson JA. Pharmacogenetics: potential for individualized drug therapy through genetics. Trends Genet. 2003;19(11):660-666.
6. Van Driest SL, Shi Y, Bowton EA, et al. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing. Clin Pharmacol Ther. 2014;95(4):423-431.
7. Scott SA, Sangkuhl K, Stein CM, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther. 2013;94(3):317-323.
8. Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA. 2001;286(18):2270-2279.
9. Crews KR, Cross SJ, McCormick JN, et al. Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm. 2011;68(2):143-150.
10. Ingelman-Sundberg M. Personalized medicine: merging pharmacogenetics and pharmacogenomics. Curr Opin Mol Ther. 2009;11(3): 280-281.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Eyad ahmed althagafi
Pharmacist, King Fahad general hospital
Fahad Rajaallah Almutairi
Pharmacist, King Fahd General Hospital
Dalia zaki baik
Technician pharmacy, King Fahad hospital jeddah
Alhussain Ali Suwayyid
Pharmacist technician, King Fahad general hospital
Yahya Ahmed Safhi
Pharmacist Technician, Al Marwa Primary Health Care Center
Turki Ahmad almoabdi
Pharmacy technician, Health Surveillance center at king Abdul Aziz Jeddah airport